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Abstract
The MR-compatibility of medical implants and devices becomes more and more important with the increasing number of high-field MR-
scanners employed. Until the end of 2004, about twenty 3 T MR in Germany will be in clinical practice. Patients with hydrocephalus need
frequent follow-up MR-examinations to assure correct functioning of a shunt. We tested three types of gravitational valves: the Paedi GAV,























dhere is strong evidence for maintenance of function of these valves after exposure to 3 T. This also implies the programmable valve, as long
s the brake mechanism is properly adjusted during MR-examination.
2005 Elsevier Ireland Ltd. All rights reserved.
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. Introduction
There is no universal protocol for the assessment of MR-
ompatibility of shunt valves in terms of function and the
pparatus to characterize the hydrodynamic performance of
alves after exposure to magnetic fields differs among man-
facturers [1,2]. In Leipzig, we overview in the group of pa-
ients who were treated by programmable Codman Medos-P
alve one patient with not adjustable device after applying
T magnetic field. So, we had to exchange the valve. That
s why we excluded programmable valves from application
n 3 T MR and initiated, together with Miethke–Aesculap,
ur study to evaluate independently their typical gravitational
alves in this high magnetism field. In 2003, the Dual Switch
nd Paedi GAV were evaluated in the Shunt Evaluation Lab-
ratory in Cambridge [4]. We employed their protocol for
his study as well and added a programmable variant of a
hunt (the proGAV) as data on changes in function are not
vailable yet. We addressed the functioning of the valve in
∗ Corresponding author. Tel.: +49 341971500; fax: +49 3419717509.
particular, as we believe that heating effects or displacement
effects are negligible. On the one hand, because the material
of the shunts does not have ferromagnetic properties, on the
other hand because the valve is in vivo well fixed underneath
the scalp [6,8,9,18].
2. Material and methods
The hydrodynamic performance of three Dual Switch
valves, three Paedi GAV valves and three proGAV valves
was evaluated before and after exposure to 3 T.
Valve characteristics:
1. Dual Switch: The Dual Switch valve is a combination of
a ball-in-cone valve and a membrane valve. It is designed
for adult patients. Two small titanium plates in the middle
of the diaphragms together with the titanium sphere fixed
in the housing act [19]. The opening pressure of different
valve-chambers is determined by two different springs for
horizontal and vertical position. All materials (titanium,E-mail address: dlind@medizin.uni-leipzig.de (D. Lindner). tantalum, silicone) are non-ferromagnetic [4,11–13].
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2. Paedi GAV: The Paedi GAV is a gravitational valve ded-
icated for management of paediatric hydrocephalus. The
inlet valve is a ball-on-spring mechanism, the outlet is
backed by a tantalum ball, which increases the operational
pressure in upright body position. It is available in six per-
formance pressure ranges [4,15].
3. proGAV: The proGAV is a programmable valve designed
for adults and children. It contains an adjustable safety
brake mechanism. After releasing the brake, the opening
pressure (in a range from 0 to 20 cm H2O) can be adjusted;
a rotor with two magnets inside the valve can be switched
from outside by a magnetic stream. All other materials (ti-
tanium, sapphire) are completely non-ferromagnetic. One
of the proGAV was tested without brake (No. SN 01004
8) to serve as a negative control.
3. Assessment of valve function
3.1. Test protocol
First, we developed a standard protocol to investigate the
valves before and after the MRI scan. Measure equipment and
test procedures were provided by C. Miethke GmbH & Co.







Figs. 2 and 3. Adjustment of the valves on the phantom model in the 3 T
MR (Siemens).
In addition, the air flow records the density of the air at
valve closure and the water flow test measures the pressure
of the ventricle [17].
3.2. MR-scanning protocol
After completion of the pre-scan tests, the valves under-
went MRI-scan. All magnetic resonance imaging (MRI) ex-
periments were performed on a 3-T human-scale whole-body
scanner (MAGNETOM Trio, Siemens, Erlangen, Germany)
using a circularly polarized head coil of birdcage design
(Bruker BioSpin, Ettlingen, Germany) and a cylindrical wa-
ter phantom provided by the manufacturer (length: 37 cm;
diameter: 17 cm; mixture of 1.24 g NiSO4·6 H2O and 2.62 g
NaCl per liter of pure water). All valves were mounted on the
side of the phantom (Figs. 2 and 3).
For MRI scanning experiments, two valves of every kind
were aligned parallel to the axis of the main magnetic field,
B0 (i.e., along the z-axis) and one of every perpendicularly
to B0.
The MRI protocol is analogous to clinical practice and
consists of a scout, T2-weighted (T2w) two-dimensionalomparable the standard ASTM F647.
.1.1. Test equipment
A roll-pump delivers a constant flow of water or air
hrough the valve in an adjustable range of 5–50 ml/h.
The valve is attached to a test dummy on a tip-over table. A
omputerized system measured the opening pressure perma-
ently with a tolerance of ±0.5 cm H2O (standard deviation)
Fig. 1).
Fig. 1. Air flow measure tool.
58 D. Lindner et al. / European Journal of Radiology 56 (2005) 56–59
(2D) spin-echo (SE) imaging, T1-weighted (T1w) three-
dimensional (3D) gradient-recalled echo (GRE) imaging
and diffusion-weighted (dw) 2D echo planar imaging (EPI).
For T2w-imaging, rapid acquisition with relaxation en-
hancement (RARE) [7] sequences (echo–train length: 13;
repetition time, TR: 6.2 s; echo time, TE: 108 ms; refo-
cusing pulse flip angle, : 150◦; acquisition bandwidth:
107 Hz/pixel; 25 slices, thickness: 2 mm, inter-slice dis-
tance: 6 mm; 2 acquisitions) were acquired with sagittal
(field of view, FOV: 220 mm× 220 mm; matrix: 512× 410;
phase-encoding along the anterior–posterior direction), coro-
nal (FOV: 220 mm× 175 mm; matrix: 512× 326; phase-
encoding along the right–left direction) and axial slice ori-
entation (identical parameters as for the coronal scan). A
sagittal 3D slab (thickness: 176 mm) was acquired for T1w-
imaging with magnetization-prepared rapid gradient echo
(MP-RAGE) [14] with selective water excitation and lin-
ear phase encoding (TR: 1.3 s for the total sequence cy-
cle; TR′: 10 ms for the GRE kernel; TE: 3.93 ms; ex-
citation pulse flip angle, : 10◦; acquisition bandwidth:
130 Hz/pixel; FOV: 256 mm× 240 mm; matrix: 256× 240;
176 partitions; 70% slice resolution; 2 acquisitions). Mag-
netization preparation consisted of a non-selective inver-
sion pulse (inversion time, TI: 650 ms). For dw-imaging,
a SE-EPI sequence [10] with fat suppression was used to






refocusing pulse to yield b-factors of 0 and 1000 s/mm2.
The valves remained in the magnet for 45 min with a to-
tal scanning time of 34:57 min. To study the effect of
the static main magnetic field separately, another set of
three valves was mounted on the phantom along the z-axis
in a second experiment and remained in the magnet for
15 min without application of radio-frequency or gradient
pulses.
Afterwards the valves were sent back for re-test of func-
tioning. The test-lab staff was blinded to which of the scan-
ning protocols was applied to a particular valve.
4. Results
The results from pre-scan and post-scan measurements
were calculated as a mean value from three single mea-
surements. The series of measurements are available for ev-
ery valve and demonstrate individual differences in tolera-
ble ranges, depending on the valve type and the influence
of flow and reflux. Tables 1 and 2 depict the differences
between the two measure times. Values were calculated as
follows:




























P 18.5ance: 3.3 mm; TR: 8.1 s; TE: 120 ms; acquisition band-
idth: 1396 Hz/pixel; FOV: 220 mm× 220 mm; matrix:
28× 80; echo position at 37.5%; 3 acquisitions). Dif-
usion weighting along 12 directions was achieved by a
air of trapezoidal gradient lobes sandwiching the 180◦
able 1
ir flow test
alve No. ∆ Horizontal P5 ml/h
ual Switch 62720202 0.8
ual Switch 28150100 0.9
ual Switch 14961197 0.4
aedi GAV 304508013 −0.5
aedi GAV 394208013 0
aedi GAV 222001003 0.2
roGAV+ SN 01010 8 0.9
roGAV+ SN 01001 8 −0.8
roGAV− SN 01004 8 −19.4 −
able 2
ater flow test
alve No. ∆ Horizontal P5 ml/h
ual Switch 62720202 1
ual Switch 28150100 1
ual Switch 14961197 1
aedi GAV 304508013 −0.8
aedi GAV 394208013 1
aedi GAV 222001003 0.5
roGAV+ SN 01010 8 −1
roGAV+ SN 01001 8 −0.5
roGAV− SN 01004 8 −19.5 −The average deviation of the valves without the negative
ontrol (No. SN 010048) was 0.6 H2O± 0.2 for the air flow
est and 0.7 H2O± 0.2 for the water flow test. Note, that the
esults for the negative control differ significantly indicating
shift of the pressure adjustment.
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5. Discussion
The aim of the study was to evaluate the function of differ-
ent valves after exposure to a 3 T MR field. The numbers of
3 T magnetoms in Germany will increase in the next years,
necessitating more knowledge about the MR-compatibility
of common devices and implants at higher field strength.
We focused on the function of the valves only. Displacement
[3,5,15] or extensive heating of the devices could not be ex-
pected due to the chemical constituents of the shunts. The
functioning of the valves is the crucial parameter. In our group
of patients with hydrocephalus who received a shunt system
we had one patient with problems after 3 T. The Medos-P
valve moved from 150 to 30 and was not longer adjustable
after magnetic application. The valve was removed as a ev-
idence for malfunction of a programmable valve that was
known to be safe at 1.5 T.
Most of the currently used valves may not be affected
by high magnetic field strength [16]. Special care has to be
taken in programmable valves. Although referring to 1.5 T
only, Zemack and Romner described adjustment problems in
2% in a retrospective study of 583 patients who were treated
with Codman Hakim programmable valve [20].
In sum, our 3 T magnetic field had no influence on stability
and safety of the tested Miethke valves. The proGAV as a
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[echanism is safely adjusted. Otherwise, a malfunction can
esult that may cause severe consequences for the patient
3,19].
This study adds to the knowledge about the MR-
ompatibility of medical implants and devices. For medico-
egal reasons we refuse liability for the use of the tested valves
t 3 T. But there is strong evidence that the valves maintain
unction after MR scanning, given the break mechanism is
roperly adjusted in the proGAV.
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